Samsung Medical Center “has succeeded in cryoballoon catheter ablation for the first time in Korea”

Samsung Medical Center revealed that it has succeeded in atrial fibrillation cryoballoon catheter ablation for the first time in Korea.


The Arrhythmia management team of the Cardiology Center (headed by Park Kyoung Min, MD, PhD, Cardiologist) has succeeded in performing their first procedure on a patient with atrial fibrillation on May 30, and the patient is now stable and in recovery.


Cryoballoon catheter ablation is a procedure that involves inserting a thin tube in the heart to find an abnormal spot that causes atrial fibrillation, and freezing it at 75℃ below zero and then removed at once.


The advantage of this procedure is that it allows a balloon to inflate in the shape of a pulmonary vein in the left atrium, which often causes atrial fibrillation, and completely remove that spot.


It is different from radiofrequency catheter ablation (RFCA), which is a conventional procedure that finds each atrial fibrillation spot one at a time and then burns it.


It has been reported that cryoballoon catheter ablation shows a much lower reoperation and readmission rate compared to RFCA; and with a confirmed evaluation that the procedure is safe and effective, it is considered as a complementary and replacement treatment in the U.S. and Europe, as well as in Japan and China.


Dr. Park Kyoung Min said that “cryoballoon catheter ablation provides a chance to open up a new treatment that is safe and effective on atrial fibrillation patients” and “my team is planning to focus on improving the treatment outcomes and increase patient safety through further studies.”